SE0102617D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0102617D0
SE0102617D0 SE0102617A SE0102617A SE0102617D0 SE 0102617 D0 SE0102617 D0 SE 0102617D0 SE 0102617 A SE0102617 A SE 0102617A SE 0102617 A SE0102617 A SE 0102617A SE 0102617 D0 SE0102617 D0 SE 0102617D0
Authority
SE
Sweden
Prior art keywords
sub
novel compounds
therapy
processes
formula
Prior art date
Application number
SE0102617A
Other languages
English (en)
Swedish (sv)
Inventor
David Griffiths
Craig Johnstone
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102617A priority Critical patent/SE0102617D0/xx
Publication of SE0102617D0 publication Critical patent/SE0102617D0/xx
Priority to IL16002302A priority patent/IL160023A0/xx
Priority to US10/484,645 priority patent/US7098240B2/en
Priority to NZ530751A priority patent/NZ530751A/en
Priority to JP2003515522A priority patent/JP2004536869A/ja
Priority to CA002454702A priority patent/CA2454702A1/en
Priority to ES02756047T priority patent/ES2280559T3/es
Priority to AT02756047T priority patent/ATE353327T1/de
Priority to DE60218048T priority patent/DE60218048T2/de
Priority to KR10-2004-7001155A priority patent/KR20040018521A/ko
Priority to CNA028152514A priority patent/CN1538968A/zh
Priority to EP02756047A priority patent/EP1421079B1/en
Priority to PCT/SE2002/001402 priority patent/WO2003010163A1/en
Priority to BR0211472-0A priority patent/BR0211472A/pt
Priority to MXPA04000755A priority patent/MXPA04000755A/es
Priority to ZA200400494A priority patent/ZA200400494B/en
Priority to NO20040314A priority patent/NO20040314L/no
Priority to JP2009291103A priority patent/JP2010111683A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE0102617A 2001-07-25 2001-07-25 Novel compounds SE0102617D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0102617A SE0102617D0 (sv) 2001-07-25 2001-07-25 Novel compounds
MXPA04000755A MXPA04000755A (es) 2001-07-25 2002-07-19 Nuevos compuestos.
DE60218048T DE60218048T2 (de) 2001-07-25 2002-07-19 Thiophenverbindungen als arzneimittel
CNA028152514A CN1538968A (zh) 2001-07-25 2002-07-19 新型化合物
NZ530751A NZ530751A (en) 2001-07-25 2002-07-19 Novel thiophene carboxamide compounds and their use as pharmaceuticals useful in the inhibition of IKK2 activity
JP2003515522A JP2004536869A (ja) 2001-07-25 2002-07-19 新規化合物
CA002454702A CA2454702A1 (en) 2001-07-25 2002-07-19 Novel compounds
ES02756047T ES2280559T3 (es) 2001-07-25 2002-07-19 Compuestos tiofenilicos como medicamentos.
AT02756047T ATE353327T1 (de) 2001-07-25 2002-07-19 Thiophenverbindungen als arzneimittel
IL16002302A IL160023A0 (en) 2001-07-25 2002-07-19 Thiopene carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them and their use in therapy
KR10-2004-7001155A KR20040018521A (ko) 2001-07-25 2002-07-19 신규 화합물
US10/484,645 US7098240B2 (en) 2001-07-25 2002-07-19 Compounds
EP02756047A EP1421079B1 (en) 2001-07-25 2002-07-19 Thiophenyl compounds as medicaments
PCT/SE2002/001402 WO2003010163A1 (en) 2001-07-25 2002-07-19 Novel compounds
BR0211472-0A BR0211472A (pt) 2001-07-25 2002-07-19 Novos compostos
ZA200400494A ZA200400494B (en) 2001-07-25 2004-01-22 Novel compounds.
NO20040314A NO20040314L (no) 2001-07-25 2004-01-23 Nye forbindelser
JP2009291103A JP2010111683A (ja) 2001-07-25 2009-12-22 新規化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102617A SE0102617D0 (sv) 2001-07-25 2001-07-25 Novel compounds

Publications (1)

Publication Number Publication Date
SE0102617D0 true SE0102617D0 (sv) 2001-07-25

Family

ID=20284945

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102617A SE0102617D0 (sv) 2001-07-25 2001-07-25 Novel compounds

Country Status (17)

Country Link
US (1) US7098240B2 (https=)
EP (1) EP1421079B1 (https=)
JP (2) JP2004536869A (https=)
KR (1) KR20040018521A (https=)
CN (1) CN1538968A (https=)
AT (1) ATE353327T1 (https=)
BR (1) BR0211472A (https=)
CA (1) CA2454702A1 (https=)
DE (1) DE60218048T2 (https=)
ES (1) ES2280559T3 (https=)
IL (1) IL160023A0 (https=)
MX (1) MXPA04000755A (https=)
NO (1) NO20040314L (https=)
NZ (1) NZ530751A (https=)
SE (1) SE0102617D0 (https=)
WO (1) WO2003010163A1 (https=)
ZA (1) ZA200400494B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
DE60229975D1 (de) * 2001-10-04 2009-01-02 Smithkline Beecham Corp Nf-kb-inhibitoren
AU2003249683A1 (en) * 2002-06-06 2003-12-22 Smithkline Beecham Corporation Nf-:b inhibitors
US7402608B2 (en) * 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US7429603B2 (en) * 2003-04-25 2008-09-30 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
US7790724B2 (en) 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
EP1493739A1 (fr) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
BRPI0418351A (pt) * 2004-01-05 2007-05-08 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
TW200626142A (en) 2004-09-21 2006-08-01 Glaxo Group Ltd Chemical compounds
BRPI0610283A2 (pt) * 2005-05-13 2010-10-19 Virochem Pharma Inc composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica
NZ563687A (en) 2005-06-30 2011-07-29 Smithkline Beecham Corp 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta)
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
CA2670260A1 (en) 2006-11-15 2008-05-22 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of flavivirus infections
CA2674865A1 (en) * 2007-01-15 2008-07-24 Santen Pharmaceutical Co., Ltd. Indole derivative having i.kappa.b kinase .beta. inhibitory activity
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
KR20130097813A (ko) 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
US8445529B2 (en) * 2008-07-14 2013-05-21 Santen Pharmaceutical Co., Ltd. Indole derivative having, carbamoyl group, ureido group and substituted oxy group
EP2319831A4 (en) * 2008-08-25 2012-10-24 Santen Pharmaceutical Co Ltd NOVEL PYRROLE DERIVATIVE WITH A UREID GROUP, AN AMINOCARBONYL GROUP AND A BIZYCLIC GROUP EQUIPPED WITH A SUBSTITUENT AS SUBSTITUENTS
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
EP2520292A1 (en) 2011-05-06 2012-11-07 Helmholtz-Zentrum für Infektionsforschung GmbH Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
JP7033789B2 (ja) 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用
CN107739370B (zh) * 2017-10-26 2021-03-30 中国药科大学 吡咯酮类brd4蛋白抑制剂的制备方法以及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468012A (en) * 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
BR9710352A (pt) 1996-07-11 1999-08-17 Pfizer Compostos piridilpirrole
PT853083E (pt) 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6037340A (en) 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
AU2713799A (en) 1998-03-12 1999-09-27 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
EP1274705A1 (en) * 2000-03-29 2003-01-15 Cyclacel Limited 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
US6414013B1 (en) 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
EP1324759A4 (en) 2000-10-12 2004-05-12 Smithkline Beecham Corp NF - G (K) B INHIBITORS

Also Published As

Publication number Publication date
CN1538968A (zh) 2004-10-20
BR0211472A (pt) 2004-11-09
MXPA04000755A (es) 2004-04-20
US20040235821A1 (en) 2004-11-25
EP1421079A1 (en) 2004-05-26
DE60218048D1 (de) 2007-03-22
WO2003010163A1 (en) 2003-02-06
NO20040314L (no) 2004-03-25
NZ530751A (en) 2005-09-30
ATE353327T1 (de) 2007-02-15
CA2454702A1 (en) 2003-02-06
US7098240B2 (en) 2006-08-29
JP2004536869A (ja) 2004-12-09
DE60218048T2 (de) 2007-08-09
KR20040018521A (ko) 2004-03-03
EP1421079B1 (en) 2007-02-07
ZA200400494B (en) 2005-04-22
JP2010111683A (ja) 2010-05-20
ES2280559T3 (es) 2007-09-16
IL160023A0 (en) 2004-06-20

Similar Documents

Publication Publication Date Title
SE0102617D0 (sv) Novel compounds
SE0102616D0 (sv) Novel compounds
GB0003154D0 (en) Novel compounds
SE0102439D0 (sv) New compounds
PT1263724E (pt) Novos compostos
SE0302116D0 (sv) Novel compounds
HRP20040317A2 (en) 1,8-naphthyridine derivatives as antidiabetics
IS6658A (is) Ný efnasambönd
SE0103836D0 (sv) Novel compounds
WO2004014902A8 (en) Compounds having an activity at metabotropic glutamate receptors
UY27368A1 (es) Nuevos compuestos
SE0100569D0 (sv) New compounds
SE0302760D0 (sv) New compounds
SE0302139D0 (sv) Novel compounds
SE0300092D0 (sv) Novel compounds
SE0300091D0 (sv) Novel compounds
SE0101038D0 (sv) Novel compounds
SE0101322D0 (sv) Novel compounds
SE0302755D0 (sv) Novel compounds
DE602004019914D1 (de) Colchicosidanaloge
ATE342906T1 (de) Tumorhemmende cerverbindungen
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"